Online inquiry

IVTScrip™ pT7-VEE-mRNA-Anti-ANGPT2&VEGFA, RG-7221 Vector   (CAT#: GTVCR-WQ2392MR)

This product GTVCR-WQ2392MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the T7 promoter to efficiently generate mRNA ecoding antibody which targeting ANGPT2&VEGFA. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter T7
Resistance Ampicillin
Species Humanized
RefSeq NM_001118887.2; NM_001025366.3
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 285; 7422
UniProt ID O15123; P15692
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pT7-VEE-mRNA-Anti-ANGPT2&VEGFA, RG-7221 Vector (GTVCR-WQ2392MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ1578MR IVTScrip™ pSP6-VEE-mRNA-Anti-PTPRC, Iomab-B Vector Vector Iomab-B
GTVCR-WQ2242MR IVTScrip™ pSP6-VEE-mRNA-Anti-PRLR, PR-1594804 Vector Vector PR-1594804
GTVCR-WQ931MR IVTScrip™ pT7-VEE-mRNA-Anti-CD40LG, CDP7657 Vector Vector CDP7657
GTVCR-WQ1319MR IVTScrip™ pT7-VEE-mRNA-Anti-APCS, GSK-2398852 Vector Vector GSK-2398852
GTVCR-WQ1455MR IVTScrip™ pT7-VEE-mRNA-Anti-F3, HuMax-TF Vector Vector HuMax-TF
GTVCR-WQ458MR IVTScrip™ pSP6-VEE-mRNA-Anti-SOST, AMG 785 Vector Vector AMG 785
GTVCR-WQ103MR IVTScrip™ pT7-VEE-mRNA-Anti-G, 62-71-3 Vector Vector 62-71-3
GTVCR-WQ250MR IVTScrip™ pT7-VEE-mRNA-Anti-Aβ15-42, ACC-001 Vector Vector ACC-001
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.